← All trials
NCT01003613
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2009
- Primary completion
- Jul 1, 2011
- Completion date
- Mar 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 32
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Hospital General Universitario de CastellónLead sponsor
- Sao Jose do Rio Preto UniversityOverall official - principal investigator
- Sao Jose do Rio Preto UniversitySponsor investigator
- Sao Jose do Rio Preto UniversityStudy chair
- University of BrasiliaCollaborator
- University of Sao PauloStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.